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Abstract
Background: Acute brain injury is an important health problem. Given the critical position of caspase 8 at the crossroads of
cell death pathways, we generated a new viable mouse line (Ncasp8
2/2), in which the gene encoding caspase 8 was
selectively deleted in neurons by cre-lox system.
Methodology/Principal Findings: Caspase 8 deletion reduced rates of neuronal cell death in primary neuronal cultures and
in whole brain organotypic coronal slice cultures prepared from 4 and 8 month old mice and cultivated up to 14 days
in vitro. Treatments of cultures with recombinant murine TNFa (100 ng/ml) or TRAIL (250 ng/mL) plus cyclohexamide
significantly protected neurons against cell death induced by these apoptosis-inducing ligands. A protective role of caspase
8 deletion in vivo was also demonstrated using a controlled cortical impact (CCI) model of traumatic brain injury (TBI) and
seizure-induced brain injury caused by kainic acid (KA). Morphometric analyses were performed using digital imaging in
conjunction with image analysis algorithms. By employing virtual images of hundreds of brain sections, we were able to
perform quantitative morphometry of histological and immunohistochemical staining data in an unbiased manner. In the
TBI model, homozygous deletion of caspase 8 resulted in reduced lesion volumes, improved post-injury motor performance,
superior learning and memory retention, decreased apoptosis, diminished proteolytic processing of caspases and caspase
substrates, and less neuronal degeneration, compared to wild type, homozygous cre, and caspase 8-floxed control mice. In
the KA model, Ncasp8
2/2 mice demonstrated superior survival, reduced seizure severity, less apoptosis, and reduced
caspase 3 processing. Uninjured aged knockout mice showed improved learning and memory, implicating a possible role
for caspase 8 in cognitive decline with aging.
Conclusions: Neuron-specific deletion of caspase 8 reduces brain damage and improves post-traumatic functional
outcomes, suggesting an important role for this caspase in pathophysiology of acute brain trauma.
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Introduction
The loss of neurons underlies the pathophysiology of numerous
neurological diseases. Understanding the key mediators of the
neuronal cell death is critical to identification of potential targets
for therapeutic intervention [1]. Caspases are highly conserved
aspartate-specific cysteine proteases that have both apoptotic and
non-apoptotic functions (reviewed in [2]).
Caspase 8 is the apical protease in the extrinsic apoptotic
pathway activated at the plasma membrane by various TNF-
family death receptors [3]. Stimulation of these receptors by pro-
apoptotic ligands causes receptor clustering followed by the
recruitment of FADD (Fas-associated death domain protein),
which in turn binds Death Effector Domains (DEDs) in the
proform of caspase 8, a protease that then cleaves and activates
downstream effector caspases responsible for apoptosis [4]. In
some types of cells, caspase 8 indirectly activates downstream
caspases by cleaving the BH3-only protein Bid [5], leading to
activation of the Apaf-1/caspase 9 apoptosome [6]. In some
scenarios, caspase 8 activation can also occur downstream of the
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pathway involving caspase 8 activation is associated with
endoplasmic reticulum (ER) stress [8,9,10,11]. Thus, caspase 8
bridges several death mechanisms, including extrinsic and intrinsic
apoptosis pathways, ER stress, and possibly autophagic pathways
(reviewed in [12]) [13].
A role for caspase 8 in neuronal cell death has been suggested by
evidence of proteolytic processing and increases in caspase 8
protease activity in the settings of ischemia [14,15] and seizures
[16,17]. However, attempts to genetically determine the function of
caspase 8 in the brain have been hampered by the observation that
caspase 8 gene knockout in mice is embryonic lethal [18]. As an
alternative, transgenic mice have been created that over-express the
endogenous caspase 8 inhibitor, c-FLIP, indirectly suggesting that
caspase 8 is a critical mediator of glucose deprivation–induced
neuronal cell death [19]. However, c-FLIP has additional functions
besides suppression of caspase 8, including induction of NF-kB
familytranscriptionfactors(reviewedin[20]),makinginterpretation
of these results difficult. To date, ablation of caspase 8 expression in
the brain of living mice has not been described.
Given the critical position of caspase 8 at the crossroads of cell
death pathways, we sought to determine the contribution of
this caspase to neuronal injury in vivo by the generation and
characterization of a new viable mouse line (Ncasp8
2/2), in which
caspase 8 has been selectively deleted in neurons. Our findings
demonstrate a protective role of caspase 8 deletion in vivo using a
controlled cortical impact (CCI) model of traumatic brain injury
(TBI) and seizure-induced brain injury caused by kainic acid (KA),
as well as in vitro employing cultures of embryonal primary cortical
neurons and adult brain coronal slices.
Materials and Methods
Experimental protocols involving vertebrate animals were
approved by the Institutional Animal Care and Use Committee
(#07-043, 07-049, 10-087, and 10-089) of the Sanford-Burnham
Medical Research Institute and comply with the National
Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals.
Generation of mouse line with neuronal ablation of
caspase 8
The generation and characterization of the CRE3 transgenic
line were summarized elsewhere [21,22]. T-cell-lineage-specific
casp8 mutant mice with deletion of exons 3 and 4 of caspase 8
(casp8
fl3-4/fl3-4; LckCre mice) [23] were backcrossed for nine
generations onto the FVB/N background to generate casp8
fl/fl
mice without cre. For deletion of the caspase 8 (casp8) gene
specifically in neurons, homozygous casp8-floxed mice (casp8
fl/fl)
were bred with pan-neuronal CRE3 homozygous transgenic mice
(FVB/N background) to obtain heterozygous founders (casp8
fl/
+cre). To generate homozygous congenic casp8
fl/flCRE3 mice, the
heterozygous founders were intercrossed for nine generations; the
Casp8/CRE3 homozygous line (henceforth named Ncasp8
2/2) was
subsequently used in most experimental procedures. Genotyping
was undertaken by PCR using primers detecting cre and casp8
flox
alleles. A cre 750-bp band was detected by forward and reverse
primers (59-GCCTGCATTACCGGTCGATGCAACGA-39 and
59 GTGGCAGATGGCGCGGCAACACCATT-39, respectively);
800-, 650- and 200-bp bands for unrecombined floxed casp8
alleles, wild-type (WT) casp8 mouse gene, as well as recombined
floxed casp8, respectively, were obtained using forward and reverse
primers (59- GGC CTT CCT GAG TAC TGT CAC CTG T-39 and
59-CCA GGA AAA GAT TTG TGT CTA GC-39).
Primary neuronal culture (PNC), treatment and viability
assay
Primary cortical neurons were derived from embryos (E16.5) of
CRE3 and Ncasp8
2/2 homozygous mice and cultured as
previously described [24]. Briefly, cortices were dissected under
a microscope in ice-cold Mg
2+ and Ca
2+ -free Hank’s Balanced
Salt Solution (HBSS, Invitrogen, Carlsbad, CA, USA), and
trypsinized (0.25% trypsin in HBSS) at 37uC for 15 min. The
tissue was mildly triturated 5–10 times and filtered through a
40 mm cell strainer (BD Biosciences, San Diego, CA, USA). The
isolated cells were counted by Trypan exclusion in a Neubauer
chamber, then seeded at a density of 75,000 cells/cm
2 on poly-D-
lysine (Sigma-Aldrich, St. Louis, MO, USA) -coated cover slips in
24 well plates and cultured in Neurobasal medium supplemented
with B27 (Invitrogen). After 3 or 14 days in culture, neurons were
treated with recombinant murine TNFa (100 ng/ml; PeproTech,
Rocky Hill, NJ, USA) and cycloheximide (CHX) (1 mg/ml; MP
Biomedicals, Solon, OH, USA) for 24 h or staurosporine (1 mM
for 4 h and 50 nM) overnight. To determine the proportion of
viable neurons, cells were fixed, then stained with Hoechst dye to
visualize nuclei and immunostained with an antibody to neuron-
specific nuclear protein (NeuN) (Chemicon, Ramona, CA, USA;
MAB377) followed by application of Alexa Fluor 594 conjugated
anti-mouse antibody (Invitrogen). The ratio of neurons with NeuN
immunoreactivity that showed Hoechst staining profile character-
istic of viable cells to the total cell number (number of Hoechst-
positive nuclei) [25,26] was determined by counting cells on ten
random fluorescent images generated by microscopy using an620
objective. In addition, to define the proportion of apoptotic/
degenerating neurons in the 14-day-old culture, a polarity sensitive
indicator for viability and apoptosis (pSIVA) (CytoGLO
TM
pSIVA-IANBD Apoptosis/Viability Microscopy Set Imgenex
IMG-6701K), dialyzed into PBS, was applied to the PNC at a
concentration of 10 mg/1 ml TC medium. In this test, fluores-
cently tagged annexin binds to externalized phosphatidylserine
exposed on apoptotic cell membranes allowing for monitoring
changes that occur at different stages of apoptosis in living
cells [27]. After 15 min incubation, the cells were fixed and
immunostained using MAP2 antibody. The ratio of pSIVA-
positive neurons with colocalized MAP2 immunopositive reactions
to total number of MAP2 positive cells was determined after
incubation with Alexa Fluor 594 conjugated anti-mouse antibody,
as described above. Using EVOS fluorescence microscope
(Advanced Microscopy Group, Bothell, WA), 15 random digital
images of cells were taken at 206magnification from 3 wells per
experiment for manual cell counting.
Brain organotypic coronal slice cultures (BOCSC)
Brain slices were prepared and cultivated using a simple method
for organotypic cultures of nervous tissue [28], slightly modified.
Briefly, 4 and 8 month old mice, representing all three
homozygous lines (3 mice/line), were anesthetized, and transcar-
dial perfusion-flush was performed with PBS containing protease
inhibitors (Sigma). After 2–3 minutes of perfusion, the mice were
quickly decapitated, the brains promptly removed, and submerged
in pre-cooled and 95% oxygenated ACSF (artificial cerebrospinal
buffer). Subsequently, both hemispheres were separated from
cerebellum and the brain stem, mounted on the vibrotome stage
with a supportive agarose block to obtain ,500–600 mm thick
coronal sections of both hemispheres using a Leica VT1200S
vibrotome. The slices were plated on organotypic inserts (Millicell
30 mm Organotypic cm PTFE 0.4 mm; Millipore/Chemicon) and
maintained for 72 h in 6-well plates on the surface of Neurobasal
A medium supplemented with B27 and GlutaMax under standard
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bregma levels from 21.22 to 3.08 were maintained in culture for
72 hours, and then treated with TRAIL (Calbiochem, La Jolla,
CA, USA) at 250 ng/mL for 4 h. Following treatment, the slices
were fixed in Z-fix solution and processed into paraffin blocks.
Additional brain slices derived from CRE3 and Ncasp8
2/2 lines
(6 mice/line) were cultured for 14 days for further processing.
Histological and immunocytochemical results were generated
using 5 mm thick serial paraffin sections numbered from 5 to 50,
counting from the bottom aspect that faces the mesh and culture
medium. The surface layer was removed by trimming before serial
sections were collected. The sections were stained either with
H&E or Masson’s trichrome or subjected to TUNEL assay or
immunostaining using antibodies specific for cleaved caspase 3
(Cell Signaling Technology, Danvers, MA, USA; cat.#9661 and
Imgenex, San Diego, CA, USA; cat.#5699), MAP2 (clone HM-2),
NeuN (clone A60 Millipore Chemicon, cat.# MAB377), b3-
tubulin (Abcam; ab18207), GFAP (Abcam, Cambridge, UK;
ab7260), S100 (DakoCytomation, Carpinteria, CA, USA; cat.#
Z0311), and Iba1 (Wako Chemicals USA, Richmond, VA; Code
No. 019-19741).
Controlled Cortical Impact (CCI) model of Traumatic Brain
Injury
Mice(12 to 28 weeks of age; weight24–38 g) of wild-type, CRE3,
casp8
fl/fl,a n dcasp8
fl/fl/cre genotypes were anesthetized with 4%
isoflurane (Aerrane; Baxter, UK) in 70% N2O and 30% O2 and
positioned in a stereotaxic frame. Using a head restraint, a 5-mm
craniotomy was made using a portable drill and a trephine over the
right parietotemporal cortex and the bone flap was removed [29].
Mice were subjected to CCI using the benchmark stereotaxic
impactor (Impact One
TM; myNeuroLab.com) with the actuator
part mounted directly on the stereotaxic instrument. The impactor
3 mm tip accelerated down to the 1.0 mm distance, reaching the
preset velocity of 3 m/s, and the applied electromagnetic force
remained there for the dwell time of 85 ms, and then retracted
automatically. The contact sensor indicated the exact point of
contact for reproducible results. Face mask anesthesia (1–2%
isoflurane in 70%/30% nitrous oxide/oxygen) was used during the
entire procedure. Afterwards, the scalp was closed with sutures,
anesthesia discontinued, and mice recovered in their cages. Sham
operated mice underwent the same surgical procedures (cranioto-
my) with the exception of the traumatic impact. Naı ¨ve animals were
not exposed to any surgical procedures. For the first 2 h post-CCI,
mice were closely monitored in their cages. Histopathological and
functional outcomes were compared between the control and
knockout mice at 2 h, 6 h, 24 h, 48 h, and 3 weeks after the trauma
(8–12 mice per time per experimental group). Sham animals were
tested at 0 h and 21 days using 4–6 mice per group.
Spatial learning and working memory performance
The Morris water maze (MWM) task was used to evaluate
spatial memory performance as described previously [30,31]. The
test was performed in a water tank for mice (122 cm diameter,
75 cm deep; San Diego Instruments, Inc., USA) filled with water
(2461uC) to 29 cm depth and divided into four quadrants of equal
size, with several well visible cues located on the walls of each
quadrant. The first cued learning tests were performed using a
visible black platform and a visible sign; performance was
evaluated by measuring latency to find the platform. Each mouse
was given four trials to find the platform. The purpose of this test
was to assess whether the experimental groups differed in the
motor or proximal visual skills necessary to locate and escape to
the platform. In the next 3 days (the acquisition learning phase),
mice learnt how to locate a clear plexiglass platform (5 cm in
diameter) submerged 0.5 cm below the surface of the water in a
quadrant different from that used in the cue trial (using external
visual cues); the water was rendered opaque by white, non-toxic
paint. The goal of this task was to evaluate how fast mice learn to
escape from the water onto the platform after being randomly
placed into the pool at one of four sites. The learning task was
performed for 3 consecutive days for each mouse before surgery
and consisted of 8 trials per day (morning and afternoon sessions)
for a total of 24 trials. Each day the start quadrant was changed
after the first trial starting from one of the points farthest from the
platform. Once the mouse found the platform, it remained there
for 10 s before beginning the next trial. The latency to reach and
climb the hidden platform within 60 s was recorded. Mice that
failed to reach the platform by 60 s, were placed on the platform
and allowed to remain there for 10 s. Mice rested in a warming
chamber for 4 min inter-trial intervals. Memory retention was
tested before the brain trauma (the next day after 3-day training)
and 1 and 3 weeks after CCI. All animals were subjected to a 1-
min probe trial of free swimming in the maze without escape
platform, and escape latency was scored. Data collection was
automated using the Any-Maze Video Tracking System (San
Diego Instruments, Inc.), thereby eliminating observer bias. A
separate cohort of 18 month old mice (casp8
fl/fl (n=19) and
Ncasp8
2/2 (n=20)) with no brain injury was also subjected to the
MWM procedure. Learning capability and extinction of memory
were tested 40 (P2) and 60 (P3) days after the cued learning phase
(P1).
Motor function assessment by the wire grip test
Vestibulomotor function was assessed using a wire-grip test
[31,32]. Mice (n=8–12/group) were placed on a metal wire
( 4 5c ml o n g )s u s p e n d e d4 5c ma b o v eaf o a mm a tb e t w e e n2
vertical bars. Mice were allowed to cross the wire for 60 s. The
latency that a mouse remained on the wire within a 60 s
interval was measured, and wire grip scores were quantified
using a 5-point scale [31,33]. Mice that were unable to remain
o nt h ew i r ef o rl e s st h a n3 0sw e r eg i v e nas c o r eo fz e r o .As c o r e
of one point was given if the mouse failed to hold on to the wire
with both sets of fore paws and hind paws together; two points
were given if the mice held on to the wire with both fore paws
and hind paws but not the tail; three points were given if the
mouse used its tail along with both fore paws and both hind
paws; four points were given if the mouse moved along the wire
on all four paws plus tail; and five points were given if mice that
scored four points also ambulated down one of the posts used to
support the wire. The wire grip test was performed in triplicate
and an average value calculated for each mouse on each day of
testing. For the statistical analysis, cumulative scores were
produced from all three trials. The test was performed before
CCI and repeated weekly after CCI through the entire duration
of the experiment (21 days). An additional cohort of aged mice
with no brain injury (described above) was also subjected to this
test.
Sensorimotor function evaluation using beam walking
test
Beam walking is a motor skill and balance test. Prior to CCI,
each mouse was trained to run across a 29.5 cm long61.2 cm
wide square wooden beam placed 33 cm above a table to reach its
home cage located at the far end of the beam. Training was
followed by a repeat test (probe 1) performed at one week before
the CCI procedure, which was repeated 7 days (probe 2) and 21
days (probe 3) after the procedure. Performance was measured as
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three times. Progressive impairment correlates with increased
numbers of foot slips during crossing. The test was also performed
on the separate cohort of aged uninjured mice (described above).
Hindlimb flexion for testing paresis and asymmetry
The hindlimb flexion was elicited by gently lifting the animal by
its tail and holding it 0.5 meters above a table [34]. The absence of
asymmetry/paresis was scored as zero (no neurological abnormal-
ities – ‘‘no’’). The presence of asymmetry/paresis was scored as
one (‘‘yes’’). The test was performed 1 week before CCI (probe 1)
and 7 and 21 days after the procedure (probes 2 and 3,
respectively).
Tissue preparation and staining
Mice were anesthetized with Avertin (BD Franklin Lakes, NY,
USA) and transcardially perfused with phosphate-buffered saline
(PBS) pH 7.4, followed by zinc-buffered formalin (Z-fix; Anatech,
Inc., Battle Creek, MI, USA). After decapitation, the whole head
was fixed in the Z-fix solution. Following skull removal and 3–5
days of brain post-fixation, each brain was cut in 1.5 mm thick
coronal slices fitting in one cassette to be processed and embedded
into a single paraffin block. Thus, all sections from each coronal
slice were stained on the same slide ensuring identical staining
conditions. In addition to H&E, brain sections were stained with
Masson’s trichrome (American Master*Tech Scientific, Inc.; Lodi,
CA, USA). Dewaxed tissue sections (4.0–5.0 mm) were immuno-
stained as reported previously [35] using an antibody to mouse
IgG (DakoCytomation), rabbit polyclonal antibodies to GFAP
(Abcam), Iba1 (Wako Chemicals USA), phospho-Tau (Thr231)
(Thermo Fisher Scientific, Lafayette, CO, USA; cat.#OPA1-
03156), phospho-Tau (T181) (Abcam ab38505), cleaved caspase 3
(Cell Signaling Technology and Imgenex), and phospho-c-Jun
(Cell Signaling Technology, cat.#9164), as well as mouse
monoclonal antibodies to NeuN (clone A60; Millipore Chemicon),
and microtubule-associated protein (MAP2) (clone HM-2; Sigma-
Aldrich), and rat monoclonal antibody to Ly-6G (BD Pharmingen;
cat#551459). Application of the primary antibody was followed
by incubation with goat anti-mouse or goat anti-rabbit polymer-
based EnVision-HRP-enzyme conjugate (DakoCytomation). Di-
aminobenzidine (DAB; DakoCytomation) and SG-Vector (Vector
Lab, Inc.; Burlingame, CA, USA) chromogens were applied,
yielding brown and black colors, respectively.
Terminal deoxyribonucleotidyl transferase–mediated
dUTP nick end-labeling (TUNEL) assay
The detection of nuclei with fragmented DNA by TUNEL was
accomplished using the ApopTag Peroxidase in situ Apoptosis
Detection Kit (Chemicon). Nuclear Red or hematoxylin were used
as counterstains.
Assessment of brain lesion volumes
We assessed volume of lesion and lesion cavity. Lesion volume
was calculated as previously reported in detail by our group [35].
Briefly, Masson’s trichrome–stained sections were digitalized using
the Aperio scanning system (Aperio Technologies; Vista, CA,
USA). Using the pen tool, virtual slides were annotated by
encircling the lesion edges (penumbra) between intact and
pathologically changed brain tissue, and the lesion area (mm
2)
was reported in the annotation window. The rostral–caudal
dimensions of the foci were determined through the use of a
stereotaxic atlas for the mouse brain [36], which was viewed
electronically side by side with the coronal section images.
Distance (mm) between coronal coordinates for bregma +1.54
(rostral position) and 23.88 (caudal position) determined the
distribution of the lesion volume. Lesion volume was calculated by
summing each lesion area multiplied by the distance between each
coronal slice. The proposed calculation is based on Cavalieri’s
method [37] modified for the purpose of volumetric analysis
performed on digital slides. The volumes of injury-induced cavities
were determined separately in a similar manner.
Quantitative analysis of immunostaining and
histochemical staining
Quantitative analysis was performed as described previously
[35]. Briefly, all slides were scanned at an absolute magnification
of 4006 [resolution of 0.25 mm/pixel (100,000 pix/in.)] using
the Aperio ScanScope CS system (Aperio Technologies). The
acquired digital images representing whole tissue sections were
analyzed applying the Spectrum Analysis algorithm package
and ImageScope analysis software (version 9; Aperio Technolo-
gies) to quantify IHC and histochemical stainings. These
algorithms make use of a color deconvolution method [38]
to separate stains. Algorithm parameters were set to achieve
concordance with manual scoring on a number of high-power
fields, including intensity thresholds for positivity and parameters
that control cell segmentation using the nuclear algorithm.
Colorimetric intensity measurements were applied to Masson’s
trichrome histochemical stain to obtain quantitative characteristics
of brain tissue damage, as well as percentage and total number of
degenerating neurons in the annotated area of interest [35]. In
addition, NeuN and MAP2 immunohistochemistry were per-
formed for assessment of neuronal cell preservation. Automated
morphometric analyses were accomplished for entire regions of
interest and not limited to a few selected fields.
Neuropathological scoring of brain injury
Brain injury was evaluated by an observer masked to the study
groups using a neuropathological scoring system: grade 0 - no
observable injury; grade 1 - restricted cortical impact area with
small petechial bleedings and variable degree of acute ischemic
neuronal degeneration but no cortical tissue loss; grade 2 - necrotic
lesion core and variable tissue loss of the injured cortex with
penumbra demonstrating neuronal degeneration limited to cortex
only; grade 3 - sporadic larger hematomas and ischemic, necrotic,
spongiotic changes crossing the corpus callosum and involving
ipsilateral hippocampal sectors CA1–CA3; and grade 4 - confluent
impact core encompassing large cortical area, entire hippocampus
and deeper thalamic structures in the upper quadrant of the
ipsilateral hemisphere. The score was given to each brain coronal
section containing a pathological focus, and the total score was a
sum of all scores for the slices recorded for each animal.
Immunoblotting
Immunoblotting methods were used to analyze proteolytic
processing of caspases and their substrates in the brains of control
and knockout mice after CCI [39]. Extracts from cortex and basal
ganglia ipsi- and contralateral to the injury site, derived from
Ncasp8
2/2, control CRE3 and casp8
fl/fl, (n=4–5 per group) were
prepared, and 30 mg of protein per lane was analyzed by SDS-
PAGE/immunobloting, probing blots with rabbit polyclonal
antibodies to caspase 8 (Imgenex IMG#5703, #5704; Cell
Signaling cat#4927), and caspase 3 (Imgenex #IMG-5699), as
well as mouse monoclonal antibody to cleaved PARP (Asp214;
19F4; Cell Signaling #9546S). Antibody to b-actin (Sigma-
Aldrich) served as a loading control. Detection was accomplished
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Piscataway, NJ, USA) multiple antigen detection immunoblotting
method, as described previously [39].
Induction of status epilepticus
Mice were injected intraperitoneally (i.p.) with kainic acid (KA)
solution (K-0250, monohydrate, Sigma) at 25 or 35 mg/kg (n=8–
11 per group). Eight control and 11 Ncasp8
2/2 mice were used in
this study. Animals were monitored during status epilepticus to
determine duration and severity of seizure activity and the
neurological status in post-seizure period.
Seizure scoring
KA-induced seizures were scored every 15 min for 2 h
according to a described procedure [40] with minor modifications
[41]. Seizure activity was scored as follows: 1 - arrest of motion; 2 -
myoclonic jerks of the head and neck with brief twitching
movements; 3 - unilateral clonic activity; 4 - bilateral forelimb
tonic and clonic activity; 5 – generalized tonic-clonic activity with
loss of postural tone; 6 - death due to continuous convulsions.
Statistical Analysis
Data were analyzed using the STATISTICA software package
(StatSoft; Tulsa, OK, USA). Statistical analyses of pairs of control
vs knockout mice or specimens were performed using a one-way
Student’s t-test. A one-way analysis of variance (ANOVA) method
was used to determine the significance of differences of multiple
point data sets. Box and whisker or column mean6SEM plots
were applied to visualize the data in a graphic form. Mean values
are plotted as a middle point at each time assessed after brain
trauma or KA treatment, while the whiskers reflect 6 standard
error of mean (SEM). Chi-square test was performed to test
whether the frequencies of neurological deficits, observed in the
hindlimb flexion test, differed significantly from the expected ones.
P values,0.05 were reported as statistically significant.
Results
Generation and characterization of mice with
neuron-specific ablation of caspase 8 expression
To establish mice with neuron-specific caspase 8 gene ablation,
we bred casp8-floxed (casp8
fl/fl) mice with transgenic pan-neuronal
CRE3 mice that express the cre protein exclusively in neurons
[21]. Consecutive breeding of heterozygotes resulted in establish-
ment of neuron-specific casp8 knockout mice, henceforth termed
Ncasp8
2/2. Genotypes were confirmed by PCR (Figure 1A).
Genomic DNA was analyzed from various tissues to determine
whether CRE3 induced recombination of the floxed-casp8 gene in
a tissue-specific manner (Figure 1B). PCR primers were designed
to differentiate unrecombined and recombined floxed-casp8,a s
well as the wild-type murine casp8 gene. Specimens from brain
(cortex, thalamus/basal ganglia, brain stem) but not from other
organs of the Ncasp8
2/2 mice and not from CRE3 (cre/casp8
+/+)
mice showed the expected PCR product of 200 bp indicative of
brain-specific recombination (Figure 1B). Immunoblot analysis
revealed decreased pro-caspase 8 levels in lysates from various
regions of brain, including cortex (C), basal ganglia (BG), and
cerebellum (CB) of the Ncasp8
2/2 mice compared to those from
CRE3 (cre/casp8
+/+)o rcasp8-floxed (casp8
fl/fl) controls (Figure 1C),
confirming that our genetic manipulations resulted in reduced
caspase 8 expression in brain. Because the cre transgene employed
is expressed only in neurons, glial expression of caspase 8 is
expected to remain [42], possibly accounting for the residual pro-
caspase 8 protein detected. Using immunohistochemistry (IHC),
brains derived from control mice (Figure 1D–G) exhibited clear
caspase 8 immunostaining in neurons and fibrous astroglia,
whereas negligible caspase 8 staining was observed in neurons in
brains from the Ncasp8
2/2 animals (Figure 1H–K). No gross or
histological brain malformations were detected in the Ncasp8
2/2
mice.
Casp8-ablated cultured embryonic neurons show
resistance to TNFa-induced cell death
To functionally verify the effects of caspase 8 deletion in murine
neurons, cultured embryonic cortical neurons from the CRE3 and
Ncasp8
2/2 homozygous mice were maintained in vitro for 3 and 14
days prior to further experimentation. Comparison of CRE3 and
Ncasp8
2/2 neurons after 14 days of culture revealed significant
differences in their phenotype and survival rates (Figure 2A, B;
Figure 3C1–D2). In contrast to sparsely distributed, clustered
control (CRE3) neurons (Figure 3C1, C2), cultures derived from
Ncasp8
2/2 homozygous mice formed dense networks of highly
branched interconnected neurons (Figure 3D1, D2). Double
staining for MAP2 (red) and pSIVA (green) [27]confirmed this
observation, revealing decreased proportion of spontaneously
degenerating neurons in the Ncasp8
2/2 culture compared to the
CRE3 control (Figure 2B, Figure 3E1–F4). After 3 and 14 days in
culture, cell death was induced using either TNFa plus
cycloheximide, an agonist of the death extrinsic apoptosis pathway
(death receptor), or staurosporine, a broad-spectrum protein
kinase inhibitor that induces the intrinsic (mitochondrial) pathway
of cell death. Consistent with a prominent role for caspase 8 in the
extrinsic pathway, casp8 gene deletion significantly protected
immature and mature neurons against cell death induced by
TNFa plus cycloheximide (Figure 2A **p=0.03, B ***p,0.0001;
Figure 3A, B, I1–J4), as determined by the ratio of remaining
(surviving) NeuN-positive neurons with Hoechst staining profile
characteristic of viable cells, relative to total cell number (number
of Hoechst-positive nuclei) (Figure 3A). Partial protection against
staurosporine-induced cell death was observed only for mature
Ncasp8
2/2 neurons (*p=0.004) but not for the immature neuronal
cells (Figure 2A). PSIVA staining of the mature neurons confirmed
this observation, demonstrating a reduced proportion of apoptot-
ic/degenerating neurons in the STS-treated and also in untreated
and TNFa/CHX-treated Ncasp8
2/2 neurons compared to the
controls (**p=0.0001; *p=0.004; ***p,0.0001) (Figure 2B;
Figure 3E1–J4). This tendency was particularly apparent in the
TNFa plus cycloheximide-treated neurons, where preserved
neuronal morphology in the Ncasp8
2/2 cultures contrasted with
the presence of devastating neuronal degeneration with loss of
axonal and dendritic branches, and numerous apoptotic bodies in
the CRE3 cultures (Figure 3I1–J4). We conclude that homozygous
deletion of genes encoding caspase 8 in neurons significantly
protects immature and mature neuronal cells against cell death
induced via the extrinsic apoptosis pathway, thus functionally
validating the genotypic and expression data above.
Neuronal deletion of casp8 protects neurons in an
organotypic culture model
In addition to assessing the impact of caspase 8 deletion in
explanted monolayer cultures of fetal neurons, we also evaluated
brain coronal slices from adult Ncasp8
2/2 mice compared to
control animals. Although brain slice cultures are well-established
models for in vitro investigations, they have been typically prepared
from early postnatal rodent brains, which show a high plasticity
and resistance to mechanical trauma during the slice preparation,
thus maintaining longer viability in culture (reviewed in [43]) [44].
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mice. Although preparation of slice cultures from older animals is
more challenging, the model is more suitable to study pathology of
the mature brain [45,46]. Unlike organotypic slices encompassing
restricted brain regions, we have deliberately prepared whole
brain slices to study cell death of neurons in mice with pan-
neuronal expression of cre recombinase, in casp8
fl/fl line, and mice
with conditional deletion of casp8 in neurons.
The aim of the present study was to determine the preservation
of neurons in mature brain slices maintained in vitro for 72 h and
14 days. First, we have analyzed ‘‘spontaneous’’ neuronal cell
death following slice preparation in the 3-day-old culture. The
insults associated with this technique, including tissue injury
(trauma), loss of cerebral blood flow (with likely ischemia/hypoxia
and hypoglycemia), and denervation (axotomy) are known to
induce cell death. Microscopic analysis of paraffin-embedded
brain slices by H&E and Masson’s trichrome staining revealed
various degrees of cellular degenerative and edematous changes,
particularly pronounced in the hippocampi and deep basal
ganglia. The survival of neurons in brain slices, however, was
maintained significantly better in the knockout compared to
control mice. The percentages of surviving neurons in brain slices
were evaluated in various regions of the brain by MAP2 and
neuron-specific nuclear protein (NeuN) immunostaining. MAP2
protein localizes predominantly to the dendrites and perikaryon of
intact neurons and is disrupted by neuronal damage [47]. As
Figure 1. Generation of mouse line (Ncasp8
2/2) with neuron-specific ablation of caspase8. (A) PCR was performed using 1 mg tail
genomic DNA for transgenic CRE3 and caspase 8
flox animals. PCR products were generated using amplification primers specific to either the cre or
casp8 genes. PCR products were analyzed by agarose gel-electrophoresis and ethidium bromide staining. Arrows indicate the cre PCR product of
750 bp and casp8 PCR products of 800 bp for floxed genes and 650 bp for wild-type casp8.( B) Brain-specific recombination of floxed casp8 genes in
CRE3 mice. Genomic DNA was isolated from various tissues of CRE3 mice containing either wild-type casp8 genes or homozygous floxed casp8 genes
(Ncasp8
2/2). PCR was performed using primers specific for casp8 (top) or the cre transgene (bottom). Brain tissues included cortex (lanes #1),
thalamus/basal ganglia (lanes #2), and brain stem (lanes #3). Arrows indicate the expected PCR products for unrecombined (fl/fl) at 650 bp,
recombined caspase8 gene knockout at ,200 bp (2/2), and wild-type unfloxed (+/+)c asp8 genes at ,800 bp. (C) SDS-PAGE immunoblot analysis
of caspase 8 protein levels in mouse brain tissues. Brain samples from cortex (C), cerebellum (CB) or basal ganglia (BG) of casp8
fl/fl-CRE3 mice
were compared with CRE3 and casp8
fl/fl animals. Lysates were normalized for total protein content (30 mg/lane) and analyzed by SDS-PAGE/
immunoblotting using antibodies specific for mouse caspase 8 (top), or b-actin (bottom), using a multiple antigen detection method [39]. (D–K)
Examples are provided of immunostaining for mouse caspase 8 in the brains of CRE3 (D–G) and Ncasp8
2/2 mice (H–K). Antibody detection was
accomplished using diaminobenzidine (DAB) chromogen (brown); nuclei were counterstained with hematoxylin (blue). Magnification scale
bar=,100 mm.
doi:10.1371/journal.pone.0024341.g001
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neurons in brain slices was highly pronounced in tissue sections
derived from CRE3 or casp8
fl/fl mice (Figure 2C, D; Figure 4A1–
A2), whereas significantly more surviving neurons were present in
brain slices from Ncasp8
2/2 animals (Figure 2C, D; Figure 4B1–
B2; Table 1). The decline in MAP2 protein expression was
associated with increased levels of cleaved caspase 3 (Figure 4A1,
A2; A2 inset – high magnification micrograph of the primary
motor cortex and hippocampus indicated by red and blue arrows).
Investigation of the entire coronal brain slices at 72 h provided
information about regional vulnerability of neurons and the
dynamics of spontaneous neuronal degeneration in organotypic
culture. Immunostaining revealed a relatively early loss of MAP2
immunoreactivity, suggesting rapid vulnerability of the microtu-
bular cytoskeleton, whereas more robust immunoreactive signals
for NeuN were detected even in neurons with balloon degener-
ation (pointed to by the red arrows in Figure 4C1, C2). In normal
mice (that contain intact caspase 8 genes), degeneration and death
of neurons occurred during the first 24 h in the entire brain. In
brain slices derived from Ncasp8
2/2 mice, the most susceptible
regions were entorhinal cortex and hippocampus, whereas
neurons in basal ganglia (particularly in the amygdala and the
bed nucleus of the stria terminalis) maintained well-preserved
morphology and MAP2 immunoreactivity for up to 3 days in
culture (Figure 4B1–D3; green arrows). Also, the median preoptic
nucleus, the dorsal part of caudate putamen, median and lateral
habenular nuclei with adjacent parafascicular thalamic nucleus,
and posterior thalamic nuclear group contained well-preserved
neurons. In neocortex of the Ncasp8
2/2 slices, neurons in
superficial cortical layers (I–II) were more affected (Figure 4D1;
red arrows), whereas deeper cortical layers (III–VI) were less
impacted by organotypic culture conditions (Figure 4D1; green
arrows). Similar regional susceptibility had been suggested in prior
reports for cultures of dissociated cortical layers [48].
Considering that at least part of neuronal cell death that
occurs in the brain slice culture model is due to signals produced
by tissue injury, we speculated that cytokines are elaborated locally
in the sliced brain tissue, resulting in caspase 8 activation. As an
example, we used the TNF-related apoptosis-inducing ligand
(TRAIL) to evoke cell death in the cultured brain slices. TRAIL is
known to transmit the apoptotic signals through death receptors
that directly activate caspase 8 [49]. Interestingly, expression of
TRAIL-binding death receptors is induced by the transcrip-
tion factor CHOP during ER stress, a condition associated with
oxidative stress and ischemia-reperfusion injury (reviewed in [50]).
In the brain organotypic culture model, casp8 gene deletion
significantly protected neurons against cell death induced by
TRAIL, as estimated in the cortical region and basal ganglia. In
contrast to control brain slices from CRE3 and casp8
fl/fl mice
where TRAIL reduced the prevalence of MAP2 and NeuN
Figure 2. Neuroprotective effects of caspase 8 gene ablation demonstrated for cultured primary neurons. (A) The ratio of surviving
NeuN-positive neurons that showed Hoechst staining profile characteristic of viable cells to the total cell number (number of Hoechst-positive nuclei)
was determined after 3 and 14 days of culture for untreated (UNT), staurosporine- (STS) and TNFa/CHX-treated primary cortical neurons derived from
embryos (E16.5) of CRE3 and Ncasp8
2/2 homozygous mice. Cells were counted on ten random fluorescent images (620). (B) The ratio of pSIVA-
positive neurons with colocalized MAP2 expression to the total number of MAP2-positive cells was determined after 14 days of culture for UNT, STS-
and TNFa/CHX-treated primary cortical neurons derived from embryos of CRE3 and Ncasp8
2/2 mice. Cells were counted on 15 random fluorescent
images (620) from 3 experiments. (C–I) Bar graphs present average percentages of MAP2 (C), NeuN (D), cleaved caspase 3 (E), GFAP (G), S100 (H),
Iba1 (I) immunopositive staining and mean percentage of TUNEL positive signaling (F) in cortices (left) and basal ganglia (right) of untreated and
TRAIL-treated cultured coronal brain slices derived from CRE3, casp8
fl/fl (Casp8 line) and Ncasp8
2/2 mice after 3 days of culture. Tables 1 and 2
provide the results of statistical analyses.
doi:10.1371/journal.pone.0024341.g002
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the number of cells expressing neuronal markers following TRAIL
treatment of Ncasp8
2/2 slices (Figure 2C, D; Figure 4G, H;
Table 1). Deletion of casp8 offered partial protection against
TRAIL-induced apoptosis in organotypic cultures, as demonstrat-
ed by significantly decreased percentages of cleaved caspase 3- and
TUNEL-positive cells in the Ncasp8
2/2 compared to CRE3 and
casp8
fl/fl brain slices (Figure 2C, D, F; Table 1). Figure 4 (E–H)
demonstrates representative images of a reciprocal pattern of
TUNEL and MAP2 expression in brain slices derived from the
control line and Ncasp8
2/2 mice.
Not only did TRAIL induce apoptosis of caspase 8-containing
neurons in organotypic brain slice cultures, but some types of glial
cells also appeared to be vulnerable to treatment with this cytokine
in the organotypic brain slice setting. In this regard, TRAIL
treatment significantly decreased the number of GFAP-positive
fibrous astroglia in all three genotype groups (Figure 2G), suggesting
that these glial cells are sensitive to TRAIL and serving as a control
to show the selective protection of neurons in Ncasp8
2/2 slices
(Figure 4K, L). Interestingly, the percentage of S100-positive
protoplasmic astrocytes did not change following TRAIL treatment
(Figure2H;Figure4I,J),implyingthattheseglialcellsareinsensitive
to TRAIL under the culture conditions tested (Table 1). Immuno-
staining for the microglial marker Iba1 increased after TRAIL
treatment in brain slice culture derived from all 3 genotypes
(Figure 2I), serving as a further indicator of the neuron-specific
differences in the responses of Ncasp8
2/2 slices to TRAIL treatment
and a sign of viability of stromal cells in the brain in vitro. After 14
days of culture, untreated Ncasp8
2/2 brain slices demonstrated
significantly more surviving neurons compared to the controls as
evidenced by higher levels of NeuN protein in the cerebral cortices
(Table 2 p=0.0004; Figure 4O, T in neocortex; Figure 4O – arrow,
P, R in archicortex/hippocampus), in basal ganglia (Figure 4O) and
higher prevalence of microtubule-associated class III b-tubulin in
gray matter, particularly in basal ganglia of the Ncasp8
2/2 brains
(Table 2 p=0.0009; Figure 4U, W). MAP2 protein was undetect-
able in the control slices and it was found only in neuropil but not in
neuronal soma in the Ncasp8
2/2 cultures. Activation of astro- and
microglia was more pronounced in Ncasp8
2/2 brain slices than in
the controls, as demonstrated by higher percentage of GFAP
(Table 2 p=0.001 in basal ganglia; Figure 4X) and Iba1 (Table 2
p=0.0004 in cortex; p=0.0003 in basal ganglia) immunostainings.
Levels of S100 protein, that visualizes protoplasmic astroglia, were
comparable at different time points for all three lines, as presented
for Ncasp8
2/2 slices at day 3 and 14 in culture (Figure 4M and N,
respectively).
Neuronal deletion of caspase 8 protects against
traumatic brain injury and facilitates learning and
memory retention in aged mice
To assess the effect of caspase 8 neuronal knockout on
functional performance and histopathological outcome following
brain injury, we subjected mice to TBI using a CCI model.
Comparisons were made of Ncasp8
2/2, CRE3 (cre/casp8
+/+),
casp8-floxed mice (casp8
fl/fl), and wild-type littermates (casp8
+/+). All
knockout (n=135) and 152 of 160 (95%) control animals survived
CCI procedure and selected groups were put through behavioral
tests. Sensorimotor function was evaluated by beam walking and
hindlimb flexion tests. All naı ¨ve control and knockout mice
learned to balance on the wooden beam (Figure 5A; probe 1).
Although all mice were impaired in their performance after CCI,
brain-injured Ncasp8
2/2 mice performed significantly better at
this task (probe 2, 3; *p=0.009; **p=0.04), demonstrating fewer
foot slips during crossing compared to their control counterparts.
In the hindlimb flexion test, none of the tested mice showed
movement asymmetry or paresis prior to the CCI procedure
(probe 1). Following the brain trauma, 6 of 7 (86%) control vs 2o f
7 (29%) Ncasp8
2/2 mice (probe 2; Chi-square p=0.03), and 6 of 7
(86%) control vs 1 of 7 (14%) Ncasp8
2/2 animals (probe 3; Chi-
square p=0.008) showed neurological deficits. To assess motor
function, we used the wire grip test. Ncasp8
2/2 mice performed
better than the control cohort (Figure 5B), with statistically
significant differences observed between groups at 7 days after
CCI (probe 2 *p=0.03). To determine the effect of neuronal
caspase 8 ablation on spatial memory acquisition, mice were
subjected to Morris water maze (MWM) test before and after CCI.
Ncasp8
2/2 mice demonstrated better learning performance to
locate the hidden platform based on visual cues, as well as superior
memory retention following the cued learning phase prior to CCI
and significantly shorter latencies after CCI compared to the
control animals (T3 *p=0.005; probe 1 **p=0.001; probe 2
***p=0.009) (Figure 5C).
Better performance of Ncasp8
2/2 mice in the wire grip and
MWM tests compared to control animals was evident also in a
cohort of aged (18 month old; casp8
fl/fl n=19, and Ncasp8
2/2
n=20) mice with no brain injury (Figure 5E *p=0.01; Figure 5F
*p=0.04, respectively), although the wire grip test revealed a
dramatic age-dependent decline in motoric performance
(p,0.0001 – probes 1–3) in all lines. Behavior of aged mice in
the beam walking test did not reveal statistically significant
differences between the genotypes (Figure 5D).
Protective effects of neuronal caspase 8 deletion on brain
histopathology after CCI
In the brain-injured Ncasp8
2/2 mice, the average lesion volume
was significantly reduced at 6 (*p=0.03), 24 (**p=0.002), and
48 h (***p=0.003) after CCI compared to the control animals
(Figure 5G). Whereas brain lesions of Ncasp8
2/2 mice were
consistently confined to the ipsilateral cortex (Figure 6A2, A4), in
caspase 8-expressing control animals the lesions often extended
beyond the cortex, reaching the white matter or even the
hippocampus (Figure 6A1, A3). Control animals also exhibited
greater average cavity volumes at later time points post injury (6 h
*p=0.02; 24 h **p=0.03) (Figures 5H and 6A1, A3). In addition
Figure 3. Caspase 8 gene ablation provides neuroprotection in vitro in primary neuronal cultures and brain organotypic cultures.
(A–B) 3-day-old PNC derived from embryos (E16.5) of CRE3 (A) and Ncasp8
2/2 homozygous mice (B) were treated with recombinant murine TNFa
and cycloheximide (CHX), then fixed and stained with Hoechst dye and immunostained with an antibody to NeuN followed by application of Alexa
Fluor 594 conjugated anti-mouse antibody. (C1–J4). Untreated (UNT C1–F4), STS-treated, (G1–H4) and recombinant murine TNFa and CHX-treated
(I1–J4) 14-day-old neuronal cultures derived from CRE3 and Ncasp8
2/2 mice were preincubated with pSIVA reagent (green) for 15 min prior to Z-fix
fixation, then immunostained for MAP2 (red) and stained with DAPI (blue). To assess neuronal phenotype, the transmission light, single (C1, D1, E4,
G1, H1, H3, I1, I2, I4, J1), double (C2, D2, E1, E2, F1, F3, G4, H2, H4, I3, J2), and triple (E3, F2, F4, G2, G3, J3, J4) channel images are
provided. Colocalization of neuronal marker MAP2 (red) with pSIVA signal (green) resulted in yellow color denoting degenerating neurons whose
number was counted and plotted as ratio to the total number of neurons (Figure 2B). Single and multichannel panels confirm specificity of the
double labeling. PSIVA was visualized from the early (membranous staining) to later stages (staining in the cell body and nucleus, the latter in cells
with loss of plasma cell integrity) of neuronal degeneration.
doi:10.1371/journal.pone.0024341.g003
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24341Figure 4. Casp8 ablation provides neuroprotection in organotypic brain slice cultures. The coronal brain slices derived from the CRE3
control line and Ncasp8
2/2 homozygous mice were maintained in in vitro conditions for 3 (A1–M) and 14 days (N–X). The presented results were
obtained from untreated (A1–D3, I, K, N–X) and TRAIL-treated (E–H, J, L) cultures. Immunohistochemical stainings are depicted in cortical and
subcortical regions of CRE3 (A1, A2, E, F, Q, S, W) and Ncasp8
2/2 (B1–D3, G–P, R, T, U, X) brain slices. Examples of single marker (M–W) and
double (A1–L, X) immunostainings are presented for S100 (M, N), NeuN (O–T), and b3-tubulin (U, W) as well as for double labeled MAP2 (DAB-
brown) and cleaved caspase 3 (SG-black; A1–B2) or GFAP (DAB; D1–D3), TUNEL (DAB; E–H) with MAP2/NeuN antibody cocktail (SG) and S100 (DAB;
I–J); IbA1 (DAB; C1–C2) or GFAP (DAB; D1–D3) with NeuN (SG) immunostaining. Scale bar indicates ,1000 mm on macro images and ,100 mmo n
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assessing neuropathological changes and anatomical extent of
brain damage. Calculation of neuropathological scores revealed
lower mean values in Ncasp8
2/2 mice compared to control
animals (*p=0.002; **p=0.02; ***p=0.004) (Figure 5I), corrob-
orating the lesion and cavity volume data, thus further indicating
that mice with neuronal caspase 8 deficiency suffer less severe
brain injury following CCI as assessed by histopathological
methods.
To assess neuronal preservation, a monoclonal antibody to
NeuN was applied in IHC studies. Strongly expressed in normal
neurons, NeuN immunoreactivity is diminished under patholog-
ical conditions, such as cerebral ischemia and brain trauma
[51,52], and proposed as a biomarker to predict delayed neuronal
degeneration after various brain injuries [53]. After CCI, the
density of NeuN-expressing neurons was significantly higher in
Ncasp8
2/2 compared to control mice, both in impact lesions
(Figure 5J; *p=0.02; **p=0.01; ***p=0.0004) and ipsilateral
semihemispheres (Figure 6B–E), approaching the values observed
in brains from naı ¨ve and sham mice at 21 day (Figure 5K).
Comparison with the corresponding contralateral cerebral regions
revealed less pronounced declines in NeuN immunoreactivity in
brains from the casp8 knockout (Figure 5M) compared to control
(Figure 5L) animals. Also, a return of NeuN immunostaining with
high magnification images of the slices. Abbreviations: DG=Dental Gyrus; CA2; CA4=sectors of hippocampus; TH=Thalamus; AMG=Amygdala;
PC=Piriformis Cortex; WM=White Matter.
doi:10.1371/journal.pone.0024341.g004
Table 1. Analysis of TUNEL assay and protein biomarkers in cortical and basal ganglia regions of untreated and TRAIL-treated
coronal brain slices (3-day-old BOCSC).
MOUSE LINES & TUNEL c-casp3 MAP2 NeuN GFAP S100 Iba1
BRAIN
REGIONS
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
CORTEX: Untreated vs TRAIL-Treated
CRE3 6362.9 vs 7163.0;
p NS
1060.4 vs 1561.2;
p=0.03
1461.7 vs 961.1;
p=0.03
2162.0 vs 860.6;
p=0.0002
761.0 vs 460.4;
p=0.03
7060.4 vs 6762.8;
p NS
260.3 vs 661.04;
p,0.0001
casp8
fl/fl 4662.3 vs 5562.9;
p NS
960.9 vs 1561.4;
p=0.007
1161.1 vs 860.7;
p=0.03
2862.3 vs 460.3;
p,0.0001
1260.8 vs 760.5;
p=0.0001
7461.8 vs 7162.1;
p NS
1.760.2 vs 560.6;
p=0.0006
Ncasp8
2/2 3762.7 vs 4162.8;
p NS
1160.8 vs 1161.1;
p NS
5361.5 vs 4961.9;
p NS
5162.3 vs 4761.9;
p NS
2760.8 vs 1061.04;
p,0.0001
8462.4 vs 8061.1;
p NS
560.3 vs 960.7;
p=0.0001
BASAL GANGLIA: Untreated vs TRAIL-Treated
CRE3 6763.1 vs 7362.6;
p NS
1461.2 vs 2161.5;
p=0.006
1262.3 vs 1061.1;
p NS
660.8 vs 560.3;
p NS
1361.4 vs 560.5;
p=0.0006
7462.3 vs 7161.6;
p NS
1.760.3 vs 260.3;
p NS
casp8
fl/fl 5862.9 vs 6560.7;
p NS
1161.1 vs 2361.4;
p=0.0002
1361.7 vs 1060.7;
p NS
1260.7 vs 260.2;
p,0.0001
1160.6 vs 760.1;
p=0.0001
7862.3 vs 7361.3;
p NS
260.3 vs 560.6;
p=0.002
Ncasp8
2/2 4361.0 vs 4662.7;
p NS
960.8 vs 1361.1;
p=0.02
5061.7 vs 4861.4;
p NS
2361.4 vs 2061.2;
p NS
2861.6 vs 860.6;
p,0.0001
8261.6 vs 7862.3;
p NS
560.3 vs 760.6;
p=0.02
CORTEX: Untreated
CRE3 vs Ncasp8
2/2 6362.9 vs 3762.7;
p=0.0002
1160.8 vs 1160.8;
p NS
1461.7 vs 5361.5;
p,0.0001
2162.0 vs 5162.3;
p,0.0001
761.0 vs 2760.8;
p,0.0001
7060.4 vs 8462.4;
p=0.0004
260.3 vs 560.3;
p,0.0001
casp8
fl/fl vs
Ncasp8
2/2
4662.3 vs 3762.7;
p=0.03
960.9 vs 1160.8;
p NS
1261.1 vs 5361.5;
p,0.0001
2862.3 vs 5162.3;
p=0.0001
1260.8 vs 2760.8;
p,0.0001
7461.8 vs 8462.4;
p=0.009
1.760.2 vs 560.3;
p,0.0001
CORTEX: TRAIL-Treated
CRE3 vs Ncasp8
2/2 7163.0 vs 4162.8;
p=0.00007
1561.2 vs 1161.1;
p=0.06 (NS)
961.1 vs 4961.9;
p,0.0001
560.3 vs 4761.9;
p,0.0001
460.4 vs 1061.04;
p=0.001
6762.8 vs 8061.1;
p=0.002
661.04 vs 960.7;
p=0.004
casp8
fl/fl vs
Ncasp8
2/2
5562.9 vs 4162.8;
p=0.008
1561.4 vs 1161.1;
p=0.06 (NS)
860.7 vs 4961.9;
p,0.0001
460.3 vs 4761.9;
p,0.0001
460.4 vs 1061.04;
p=0.047
7461.8 vs 8061.1;
p=0.003
1.760.2 vs 960.7;
p=0.002
BASAL GANGLIA: Untreated
CRE3 vs Ncasp8
2/2 6763.1 vs 4361.0;
p=0.00008
1461.2 vs 960.8;
p=0.01
1262.3 vs 5061.7;
p,0.0001
660.8 vs 2361.4;
p,0.0001
1361.4 vs 2861.6;
p=0.0001
7462.3 vs 8261.6;
p=0.01
1.760.3 vs 560.3;
p,0.0001
casp8
fl/fl vs
Ncasp8
2/2
5862.9 vs 4361.0;
p=0.001
1161.1 vs 960.8;
p NS
1361.7 vs 5061.7;
p,0.0001
1260.7 vs 2361.4;
p=0.0001
1160.6 vs 2861.6;
p,0.0001
7862.3 vs 8261.6;
p NS
260.3 vs 560.3;
p,0.0001
BASAL GANGLIA: TRAIL-Treated
CRE3 vs Ncasp8
2/2 7362.6 vs 4662.7;
p=0.00008
2161.5 vs 1361.1;
p=0.003
1061.1 vs 4861.4;
p,0.0001
560.3 vs 2061.2;
p,0.0001
560.5 vs 860.6;
p=0.03
7161.6 vs 7862.3;
p=0.04
260.3 vs 760.6;
p=0.0001
casp8
fl/fl vs
Ncasp8
2/2
6560.7 vs 4662.7;
p=0.0001
2361.4 vs 1361.1;
p=0.0006
1060.7 vs 4861.4;
p,0.0001
260.2.0 vs 2061.2;
p,0.0001
760.1 vs 860.6;
p NS
7361.3 vs 7862.3;
p NS
560.6 vs 760.6;
p=0.04
Statistical analyses of control (CRE3, casp8
fl/fl) vs Ncasp8
2/2 mouse specimens were performed using Student’s t-test. The resulting average percentages of positive/
immunopositive cells and standard error of mean (SEM) values are provided. P values,0.05 are reported as statistically significant. ‘‘NS’’ stands for nonsignificant
(p$0.05).
doi:10.1371/journal.pone.0024341.t001
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Ncasp8
2/2 regions was noted at 21 day following brain trauma
(Figure 5M, N). The differences we observed in NeuN immuno-
reactivity may be indicative of a protective effect of neuronal
caspase 8 deletion on survival of neurons, but it should be noted
that loss of NeuN immunostaining theoretically could be
attributed to depletion of NeuN protein and not necessarily to
neuronal disintegration or death [53,54].
Microtubule-associated proteins (MAPs), such as MAP2 and
tau, are known to be sensitive markers of neuronal injury. In our
TBI study, loss of MAP2 immunostaining following CCI
indicated an early vulnerability of the microtubular cytoskeleton
to brain trauma not only in the contused but also to a lesser
extent in the contralateral cortex (Figure 6F1–F4). A correlation
was observed between loss of MAP2 protein and neuronal
damage as revealed by Masson’s trichrome staining. Compari-
sons of caspase 8 deficient and control mice revealed that average
levels of MAP2 protein remained higher in the impact lesions of
Ncasp8
2/2 mice compared to control animals (*p=0.002 at 6 h)
(Figure 5O, P). We also analyzed phospho-tau levels by IHC.
Hyperphosphorylation impairs the microtubule binding function
of tau, ultimately leading to the degeneration of the affected
neurons in a range of neuronal insults [55]. At 21 days after CCI,
levels of hyperphosphorylated forms of tau protein in the
ipsilateral semihemispheres of the brain-injured control mice
exceeded by at least two-fold the phospho-tau protein levels in
mice with neuronal deletion of caspase 8 (*p=0.001) (Figures 5Q
and 6G–J).
Reduced cell death and caspase processing in injured
brains of mice with neuronal caspase 8 deficiency
To qualitatively and quantitatively characterize neuronal cell
death, we applied measurements of colorimetric intensity to a
histochemical Masson’s trichrome stain [35]. Morphologic
criteria identified with this stain assist in distinguishing degener-
ating and ischemic neurons (chromatin clumps are basophilic -
‘‘dark blue neurons’’, while the rest of the cell is eosinophilic) and
shrunken necrotic neuronal cells characterized by brightly
eosinophilic cytoplasm [35]. The percentage of degenerating
cells in lesions was significantly higher in control mice compared
to Ncasp8
2/2 animals (*p=,.0001; **p=0.003; ***p=0.02)
(Figure 6K1). Similar conclusions were reached when the number
of degenerating cells per lesion area (n/mm
2) was calculated
(*p=0.0001; **p,.0001; ***p=0.05;****p=0.01) (Figure 6K2).
Apoptosis contributes to neuronal cell death. Caspase 3 is
activated by most apoptotic stimuli, becoming proteolytically
cleaved to generate immunodetectable neo-epitopes [56]. In our
TBI experiments, the percentage of cells with cleaved caspase 3
immunopositivity was elevated at 2 h post CCI in the lesion and
penumbra, declining at 21 day after brain trauma. Although
showing a similar kinetics of caspase 3 expression, the percentage
of cells with caspase 3-positive cells remained significantly lower in
the lesion and penumbra region of Ncasp8
2/2 mice compared to
control animals (Figure 6L1; *p=0.02). Similar observations were
made when the density of cleaved caspase 3-positive cells was
calculated (*p=0.02; **p=0.03) (Figure 6L2).
Caspase 8 cleaves and activates the effector caspase 3 to cleave
PARP thus connecting this protease to the mitochondrial pathway
for cell death (reviewed in [12]). By immunoblotting, we observed
a depletion of the caspase 8 proform in the impact lesion samples
from the control CRE3 and Casp8
fl/fl but not Ncasp8
2/2 mice;
caspase 8 proform was detected in contralateral hemispheres
(CLH) of all experimental groups (Figure 6M). Strong bands
corresponding to cleaved PARP were recognized in lesion samples
from the control CRE3 and Casp8
fl/fl but not Ncasp8
2/2 mice.
Barely detectable cleaved PARP levels were noted in the
contralateral hemisphere samples (Figure 6M).
The c-Jun N-terminal protein kinase (JNK) signaling pathway
modulates the activity of several Bcl-2 family proteins, promoting
apoptosis [57,58]. At 2 days following CCI, the frequency or
density of cells with nuclear phospho-c-Jun in the lesion and
surrounding penumbra significantly increased in control
(Figure 6N–R) but not in Ncasp8
2/2 (Figure 6S–X) mice
(Figure 6Y,Z) (Y: *p=0.03; Z: *p=0.02; **p=0.05). Nuclear
immunoreactivity of phospho-c-Jun was barely present in the
contralateral semihemisphere of control mice, thus confirming that
the elevated nuclear expression of c-Jun is trauma-related.
Assessment of the blood-brain barrier, reactive gliosis
and inflammatory response in the post-traumatic brains
Post-traumatic alterations in the blood-brain barrier (BBB) were
determined immunohistochemically by assessing extravasation of
mouse immunoglobulin G (mIgG). The immunostaining demon-
strated greater extravasation of mIgG in impact lesion/penumbra
Table 2. Analysis of TUNEL assay and protein biomarkers in cortical and basal ganglia regions of untreated 14-day-old organotypic
brain slice cultures (BOCSC).
MOUSE LINES & TUNEL c-casp3 MAP2 NeuN b3 tubulin GFAP S100 Iba1
BRAIN
REGIONS
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
(mean±SEM);
p value
CORTEX:
CRE3 vs
Ncasp8
2/2
7262.4 vs
6068.0; p NS
4166.6 vs
5367.9; p NS
1661.7 vs
1362.7; p NS
3261.4 vs
5764.5;
p=0.0004
3964.5 vs
4463.3; p NS
2164.9 vs
2562.1; p NS
5162.7 vs
4961.6; p NS
5162.7 vs
4961.6;
p=0.0004
BASAL GANGLIA:
CRE3 vs
Ncasp8
2/2
6861.8 vs
6265.9; p NS
2965.5 vs
3964.9; p NS
1561.4 vs
1161.9; p NS
1663.9 vs
2463.1; p NS
2761.6 vs
2463.1
p=0.0009
1561.7 vs
2661.7;
p=0.001
5365.8 vs
5762.0;
p NS
860.9 vs
2062.0;
p=0.0003
Statistical analyses of control CRE3 vs Ncasp8
2/2 mouse specimens were performed using Student’s t-test. The resulting average percentages of positive/
immunopositive cells and standard error of mean (SEM) values are provided. P values,0.05 are reported as statistically significant. ‘‘NS’’ stands for nonsignificant
(p$0.05).
doi:10.1371/journal.pone.0024341.t002
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Ncasp8
2/2 mice (Figure 7A, D–K). The extravasation area
decreased significantly by 21 days post CCI in the casp8 knockout
but not in the control animals (*p=0.02; **p=0.04) (Figure 7A).
A comparison of microglia density between the experimental
groups was accomplished by measuring the percentage of IbA1
positive cells in the annotated ipsilateral semihemispheres at
different time points after CCI (Figure 7B). The dynamics of
changes in microglia prevalence were similar in both experimental
groups with higher density of activated microglia with hypertro-
phic soma and thick processes in the Ncasp8
2/2 mice, most
pronounced at 21 day post CCI (Figure 7B (*p=0.02) and L–S).
TBI causes active astrogliosis, which may cause glial scar
formation and promote activation of microglia [59]. Increased
frequencies of GFAP-immunopositive activated astroglia were
observed in ipsilateral regions of both control and Ncasp8
2/2)
mice compared to the contralateral semihemispheres, with no
statistically significant difference between the control and
Ncasp8
2/2 mice (not shown). Recent studies revealed that reactive
astrocytes undergo substantial molecular changes that dictate their
beneficial function for neuronal survival [60]. Histological
examination of the leukocyte infiltration into brain hemispheres
following CCI indicated a delayed influx of neutrophils (Ly6G+
cells) into the damaged area in mice lacking neuronal caspase 8
compared to controls (Figure 7C; *p=0.03; **p=0.02).
Caspase 8 deletion protects against seizure-induced
brain injury caused by kainic acid (KA)
Systemic administration of excitotoxic glutamate receptor
agonist KA induces seizures and subsequent neuronal damage
[61,62]. We treated Ncasp8
2/2 and control mice with KA to
investigate the role of caspase 8 in excitotoxicity-induced brain
injury. Observation and scoring of convulsions revealed shorter
mouse survival (Figure 8A) and greater severity of seizures
(Figure 8B; *p=0.008) in the control group compared to the
Ncasp8
2/2 mice. To determine whether neuronal ablation of
caspase 8 plays a protective role in KA-induced hippocampal cell
death, the numbers of apoptotic and degenerating neurons were
assessed by TUNEL assay (Figure 8C (*p=0.002), G, H) and
Masson’s trichrome stain (Figure 8D (*p=0.005), E, F) in
hippocampal regions. Neuronal cell death (particularly abundant
in the CA3 region) was decreased by caspase 8 deletion, as assessed
by both methods. Results of cleaved-caspase-3 immunostaining
confirmed this observation (Figure 8I–K).
Discussion
Acute brain injury constitutes a leading cause of disability and
death. Devising therapeutic strategies for ameliorating irreversible
loss of neurological function from these disorders begins with
identifying targets for drug discovery. In this study, we provide
evidence that neuron-specific deletion of caspase 8 reduces brain
damage and improves functional outcomes induced by CCI in
mice, suggesting an important role for this caspase in the
pathophysiology of brain trauma. The protective effect of neuronal
ablation of caspase 8 was evident by reduced lesion and cavity
volumes, the lower neuropathological scores, reduced frequencies
of neuronal cell death, reduced numbers of cells with cleaved
caspase 3, better learning performance, superior retention of
spatial memory and improved sensorimotor function. Interesting-
ly, better learning performance and superior memory retention
were also observed in aged Ncasp8
2/2 mice with no brain injury.
Alterations in CNS are known to underlie age-related impairment
of motoric function. In the wire grip test, age-related decline in
motoric performance is reduced in the casp8 knockout mice
compared to the age-matched controls. Further studies will be
necessary to examine the effects of neuronal depletion of caspase 8
on learning and motoric function and to provide clues as to the
mechanisms by which neuronal deletion of caspase 8 affects
cognitive and behavioral function.
Neuronal caspase 8 deficiency also protected against neuronal
injury caused by KA-induced excitotoxicity and seizures. Excito-
toxicity contributes to secondary damage and cell death following
acute brain injury [63] and is caused by excessive release of
excitatory amino acids such as glutamate and aspartate that
stimulate various glutamate receptors [64]. Neuronal cell death in
hippocampus was diminished by caspase 8 deletion.
Ncasp8
2/2 mice showed reduced phospho-c-Jun levels after
TBI. Inhibition of c-Jun activity through the expression of a
dominant negative c-Jun mutant or injection of neutralizing
Figure 5. Caspase 8 deficiency affects functional and histopathological outcome following TBI and facilitates learning and memory
retention in aged mice. (A) Sensorimotor function was measured as the number of foot slips while traversing the length of the beam three times
in the beam walking trial. Training was followed by probe 1 (one week interval) before CCI procedure and repeated 7 and 21 days after the procedure
(probe 2 and 3). P values result from Student’s t-test (*p=0.009; **p=0.04). (B) Wire grip scores were quantified using a 5-point scale [33] to assess
motor function. Tests were conducted 1 day before CCI (probe 1) and 7 (probe 2; *p=0.03) and 21 days (probe 3) after brain trauma. (C) Morris water
maze (MWM) performance was tested in the control (Ctrl; n=12) and Ncasp8
2/2 (n=15) mice. Average latency to reach and climb the platform or
enter the platform zone before and after CCI is shown (mean6SEM) (*p=0.005; **p=0.001; ***p=0.009). Beam walking (D) and wire grip (E) tests
were conducted in uninjured 18 month old casp8
fl/fl (Ctrl; n=19) and Ncasp8
2/2 (n=20) mice (3 testing sessions, spaced one week apart). P values
result from Student’s t-test (*p=0.01). (F) MWM task was performed in the same aged cohort to test memory retention up to 60 days after
completion of the learning sessions. Average latency to reach and climb the platform is shown (mean6SEM) (*p=0.04). (G–I) Histopathological
outcomes were compared between the control (Ctrl) and Ncasp8
2/2 mice 2 h, 6 h, 24 h, 48 h, and 3 weeks after the trauma (8–10 mice per time
point in each experimental group). Using Aperio scanning system, lesion (G) and cavity (H) volumes were determined by summing each lesion or
cavity area multiplied by the distance between each coronal slice (mean6SEM). Plots depict average lesion volume (G:* p=0.03; **p=0.002;
***p=0.003), cavity volume (H:* p=0.02; **p=0.03), and neuropathological scores (I:* p=0.002; **p=0.02; ***p=0.004). (J) Time course for density
(n/mm
2) of NeuN-immunopositive neurons in traumatic brain lesions is depicted for the control (Ctrl) and Ncasp8
2/2 mice. (K) The NeuN
immunostaining results are compared among the six experimental groups [control (Ctrl) and Ncasp8
2/2 naı ¨ve (no surgery ‘‘-’’), sham (surgery ‘‘S’’),
and subjected to CCI (‘‘C’’) mice] in impact lesions (CCI-treated) or corresponding regions (naı ¨ve or sham-operated) at 21 day after procedure. Density
(n/mm
2) of NeuN-immunopositive neurons in impact lesions or matching ipsilateral regions (IL) and corresponding contralateral (CL) regions of the
control (Ctrl) (L) and Ncasp8
2/2 (M) naı ¨ve (no surgery ‘‘-’’), sham (surgery ‘‘S’’), and subjected to CCI (‘‘C’’) mice is presented in a time-course manner
(L, M) or at 21 day after procedure (N)( J:* p=0.02; **p=0.01; ***p=0.0004; L:* p=0.0005; **p,.0001; ***p=0.0008; M:* p=0.0002; **p=0.006;
***p=0.002; ****p=0.0007). (O–P) Percentages of MAP2 immunopositive neurons were compared in impact lesions or corresponding ipsilateral
regions of the control (Ctrl) and Ncasp8
2/2 naı ¨ve (no surgery ‘‘-’’), sham (surgery ‘‘S’’), and subjected to CCI (‘‘C’’) mice (8–10 mice/time point/group)
and presented as time-course data (O) at 5 time points post CCI (mean6SEM) (L:* p=0.002) and at 21 day after CCI (bar graph)(P). (Q) Phospho-tau
immunoreactivity was assessed in ipsilateral semihemispheres of the control and Ncasp8
2/2 mice 48 h and 3 weeks after CCI (n=8–10 per group)
(mean 6 SEM *p=0.001).
doi:10.1371/journal.pone.0024341.g005
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by withdrawal of nerve growth factor (NGF) or chronic
depolarization [65,66,67]. Thus, the improved outcomes in
Ncasp8
2/2 mice may be, at least in part, attributable to reduced
signaling through pathways leading to c-Jun phosphorylation. In
this regard, caspases have been reported to cleave and activate
kinases upstream of JNK [68], which could explain why caspase 8
deficiency reduces c-Jun phosphorylation. Our finding that c-Jun
phosphorylation occurs downstream of caspase 8 in in vivo models
of acute brain injury provides a novel mechanistic insight and
argues against using chemical inhibitors of c-Jun kinases (JNKs) as
a therapeutic strategy for amelioration of neurotrauma, favoring
targeting of caspase 8.
Diffuse axonal injury is a primary feature of head trauma and
one of the most frequent causes of morbidity [69]. In humans, a
post-translationally modified form of tau in the cerebrospinal fluid
(CSF) of TBI patients was elevated over 1000-fold when compared
to non-TBI patients, and assisted in quantification of axonal
damage, with decreased levels of this protein associated with
clinical improvement [69]. Thus, reduced phospho-tau protein
levels in the injured semihemispheres of casp8 knockout mice at 21
days post-TBI may be predictive of attenuated axonal injury
responses. This novel observation warrants further investigation
and indicates a potential for utilizing our mouse line for future
exploration of TBI, Alzheimer’s disease (AD), and a possible link
between both pathologies. In this regard, it may be relevant that a
history of TBI is one of the strongest risk factors identified to date
for risk of AD (reviewed in [70]).
Loss of MAP2 immunostaining suggests an early vulnerability of
the microtubular cytoskeleton to brain trauma. However, the
observed subsequent increase in MAP2 immunoreactivity in
Ncasp8
2/2 brains provides evidence that this alteration was more
commonly reversible in caspase 8-deprived neurons, consistent
with improved overall neuronal survival.
Enhanced microgliosis was observed in Ncasp8
2/2 brains,
indicating that microglia activation does not require a contribution
from caspase 8 expressing neurons. A primarily neuroprotective
role of activated microglia after ischemia has been proposed,
rendering anti-inflammatory treatment within the protective time
window of microglia counterintuitive [71]. Microglia are noted for
their production of cytokines, including TNFa. In the absence of
caspase 8, TNFa exerts a primarily cytoprotective phenotype
mediated largely by NF-kB (reviewed in [72]). In addition, our
animal model results demonstrate that caspase 8 modulates the
kinetics of neutrophil infiltration into damaged brain, suggesting
an impact on generation of chemotactic regulators.
Growing evidence suggests that the extrinsic apoptotic pathway
contributes to neuronal cell death in TBI. Elevated expression of
the TNF family death receptor Fas and its ligand FasL in neurons
was observed after CCI injury in rats [73]. Previously, we observed
caspase 8 activation following CCI in adult rats [42]. Proteolysis of
caspase 8 has been reported in rat brains after fluid percussion
injury [74], and in human brains after head trauma [75].
Inhibiting caspase 8 by peptidyl caspase 8 inhibitor isoleucinyl-
glutamyl-threoninyl-aspartyl-aldehyde (IETD-CHO) reportedly
reduces ischemic brain injury in newborn rats [76]. While
providing further evidence for a role of caspase 8 in neuronal
cell death, such peptidyl protease inhibitors are known to cross-
react on other members of the caspase family, limiting
interpretations [77]. Additionally, upstream activators of caspase
8, such as Fas-associated DISC formation, have been reported in
neurons after TBI in mice and humans [78]. Fas inhibition in
Fas
lpr/lpr mice reduced cell death, and improved function in rodent
spinal cord injury [79]. TBI experiments performed on TNFa-
deficient mice revealed an early but not sustained neuroprotective
effect of TNFa inhibition [80]. However, dual deficiency of TNFa
and Fas in mice subjected to CCI significantly reduced long-term
brain tissue damage in both immature and adult mice, suggesting
that protective effects of this double gene deletion are age-
independent and long-lasting [81]. In our study, casp8-ablated
cultured neurons show significant resistance to TNF-a in both
immature and mature neurons, whereas only partial protection
against staurosporine-induced cell death was observed for the
mature but not for the immature neuronal cells, corroborating
observations from casp8 gene knockout experiments that caspase 8
activation is not necessary for caspase 9-mediated apoptosis [18].
While ablating caspase 8 expression would be expected to
inhibit apoptosis induced by TNF family death receptors, some
TNF-family cytokine receptors reportedly induce non-apoptotic
cell death, raising concerns about whether interfering with
caspases would be sufficient to provide neuroprotection in vivo.
In particular, TNFR1 can stimulate the activation of a necrotic
cell death pathway involving kinases Rip1 and Rip3 [82], in
addition to apoptotic pathways mediated by caspase 8. Additional
concerns about the effects of caspase inhibition arise from reports
that caspases antagonize autophagic cell death mechanisms [12].
Induction of Rip1-dependent autophagy (instead of necrosis) was
reported after exposure to zVAD-fmk or specific knockdown of
Figure 6. Assessment of lesion volume, cell death and immunoreactivity for MAP2, NeuN, and phospho-tau in control and Ncasp8
2/2
brains after CCI. (A1–A4) Masson’s trichrome–stained brain sections were digitalized using the Aperio scanning system. Digitized virtual slides
were annotated by encircling the brain tissue loss (cavity) and lesion edges (penumbra) between intact and pathologically changed brain tissue of
the control (A1, A3) and Ncasp8
2/2 (A2, A4) mice. Scale bar=,1000 mm on low and ,100 mm on high magnification images. Examples of nuclear
NeuN (B–E) and the perikaryonal and dendritic MAP2 (F1–F4) immunostaining are presented in the coronal brain sections (F1, F2), cortical lesions
and adjacent structures (B–E, F3, F4) of the control (B, C, F1, F3) and Ncasp8
2/2 (D, E, F2, F4) mice after CCI. Scale bar=,1000 mm on low (F1,
F2) and ,100 mm on higher magnification images (B–E, F3, F4). Examples of phospho-tau immunostaining in control (G, H) and Ncasp8
2/2 (I, J)
brains are provided at low and high-power magnifications (scale bar=,100 mm). Using Aperio software, percentage (K1, L1) and density (n/mm
2)
(K2, L2) of degenerating (K1,2) and apoptotic (L1,2) neurons was identified by Masson’s trichrome stain and cleaved caspase 3 immunostaining,
respectively (mean6SEM; n=8–10 per group and per time point) in lesion areas of brains from CRE3 (white bar) and Ncasp8
2/2 (black bar) mice at
2 h, 6 h, 24 h, 48 h, and 3 weeks after trauma (K1:* p=,.0001; **p=0.003; ***p=0.02, K2:* p=0.0001; **p,.0001; ***p=0.05; ****p=0.01; L1:
*p=0.02; L2: *p=0.02; **p=0.03). (M) SDS-PAGE immunoblot analysis of caspase 3 and cleaved PARP protein levels in mouse brain tissues. Brain
samples from impact lesion and corresponding region in the contralateral hemisphere (CLH) of Ncasp8
2/2 mice (lanes 3, 6) were compared with
those from CRE3 (lanes 1, 4) and casp8
fl/fl (lanes 2, 5) animals. Lysates were normalized for total protein content (30 mg/lane) and analyzed by SDS-
PAGE/immunoblotting using antibodies specific for caspase 3, cleaved PARP, or b-actin, using a multiple antigen detection method [39]. (N–X)
Examples are provided of phospho-c-Jun immunostaining in ipsilateral semi-hemispheres of brains from the control (N–R) and Ncasp8
2/2 (S–X) mice
(magnification scale bar=,100 mm). Antibody detection was accomplished using polymer-based EnVision-HRP-enzyme conjugate (DakoCytoma-
tion) and diaminobenzidine (DAB) chromogen (brown); nuclei were counterstained with hematoxylin (blue). Percentage (Y) and density (Z)o f
phospho-c-Jun immunopositive nuclei were determined in impact lesions from control (white bar; Ctrl) and Ncasp8
2/2 (black bar) animals at 6, 24,
48 h, and 21 days post CCI (mean6SEM; n=8–10 mice per group and per time point) (Y:* p=0.03; Z:* p=0.02; **p=0.05).
doi:10.1371/journal.pone.0024341.g006
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traumatic mouse brains. (A) Percentage of mIgG positive immunostaining was determined at various times in lesion or corresponding ipsilateral
areas of the control (Ctrl) and Ncasp8
2/2 sham- or CCI-treated mice (8–10 mice per group) (mean6SEM; *p=0.02; **p=0.04). (B) Percentage of IbA1
immunopositive cells was compared in ipsilateral semihemispheres of the control vs Ncasp8
2/2 sham- or CCI-treated mice (*p=0.02). (C) Neutrophil
density (n/mm
2) was determined by Ly6G immunostaining and compared in ipsilateral (IL) and contralateral (CL) semihemispheres of the CRE3 (Ctrl)
and Ncasp8
2/2 mice at various times after CCI (*p=0.03; **p=0.02). Examples of digital (D, F, H, J) and mark-up (E, G, I, K) images of mIgG
immunostaining are presented in brains from the control and Ncasp8
2/2 mice 48 h (D–G) and 3 weeks (H–K) after CCI. Brown color (DAB) on digital
images and red, orange and yellow pixels on mark-up images denote positive immunostaining (magnification scale bar=,1000 mm). Digital (L, N, P,
R) and mark-up (M, O, Q, S) images of the IbA1 (L–S) immunostainings are presented in the ipsilateral semihemispheres of the control (L, M, P, Q)
and Ncasp8
2/2 (N, O, R, S) mice after brain trauma. Magnification scale bar=,100 mm. Insets show 800–1,2006magnification of activated microglia
(P, R).
doi:10.1371/journal.pone.0024341.g007
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PLoS ONE | www.plosone.org 17 September 2011 | Volume 6 | Issue 9 | e24341Figure 8. Caspase 8 deficiency protects neurons in in vivo KA-induced seizure mouse model. (A) Mouse survival was monitored for
24 hours after exposure of control (n=8) and Ncasp8
2/2 mice (n=11) to KA. Non-linear x-axis corresponds to time following KA injection. (B) Seizure
scores for control and Ncasp8
2/2 mice were determined every 15 min for 2 h and at longer intervals thereafter [40] [41]. Percentage of TUNEL-
positive neurons (C) and density of degenerating neurons (Masson’s trichrome stain) (D) were assessed in the hippocampi of the control and
Ncasp8
2/2 mice (mean6SEM). P values result from Student’s t-test (B:* p=0.008; C:* p=0.002; D:* p=0.005). Colorimetric intensity measurements
were applied to Masson’s trichrome-stained control (E) and Ncasp8
2/2 (F) hippocampi to obtain density of degenerating neurons in the annotated
area (mark-up images). Arrows indicate hippocampal CA3–CA4 sectors and the hilus (E) and the CA3 sector (F). Apoptotic neurons were visualized by
TUNEL assay (G, H), and cleaved-caspase 3 immunostaining (I–K) as presented on virtual (I, K) and mark-up (G, H, J) images of the hippocampal
regions of the control (G, I, J) and Ncasp8
2/2 (H, K) mice. Brown color (DAB) on digital images and red, orange and yellow pixels on mark-up images
denote positive staining. The arrow indicates TUNEL positive neurons in the CA3–CA4 sector.
doi:10.1371/journal.pone.0024341.g008
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suggesting that the absence of caspase activity favors induction of
autophagic cell death. Also lymphocytes in which caspase 8 was
reduced by RNAi showed an increased tendency towards
autophagy [83]. While associated with cell death, autophagy is
often viewed as a survival mechanism during times of nutrient
insufficiency and hypoxia (ATP depletion) (reviewed in [85]). With
respect to brain injury, autophagy was shown to be persistently
activated after TBI, and was proposed to represent a protective
mechanism [86]. Thus, if caspases oppose autophagy as previously
suggested [87], then gene ablation of caspase 8 would be
anticipated perhaps to promote autophagy, which might enhance
neuronal survival in the setting of decreased ATP resulting from
acute brain injury caused by TBI.
Following TBI and KA-induced seizures, we observed reduced
apoptosis of neurons in brains of mice lacking neuronal caspase 8,
as demonstrated by Masson’s trichrome and TUNEL stainings or
cleaved caspase 3 immunostainings. Reduced lesion cavity volume
in Ncasp8
2/2 mice subjected to CCI, as well as improved
neuropathological scores, indicated that necrotic processes are less
(not more) pronounced in brains from caspase 8 knockout mice
compared to control animals, thus alleviating concerns about
whether interfering with caspase 8 would promote increased brain
damage by necrosis.
It is noteworthy that hundreds of measurements conducted in
this study were done using image analysis algorithms. Unlike
semiquantitative manual scoring, computer-based image analysis
permits objective quantification on entire tissue sections or
anatomical regions of interest.
In addition to in vivo models of brain injury, we have utilized in
vitro models including primary cortical neuron cultures and
organotypic brain slices to characterize effects of conditional
deletion of caspase 8 on neuronal survival and death. Together,
these results provide additional evidence of protective effect of
neuronal deletion of caspase 8, corroborating the in vivo data. For
undertaking these studies, we established an improved organotypic
whole brain slice culture method using tissue from adult (4–8
month old) mice, wherein viable brain structures are maintained
for up to 14 days, as evidenced by preserved morphological
architecture, expression of neuronal markers (NeuN, b3-tubulin),
and concomitant glial reactions. Gradually declining levels of
MAP2 protein in brain slices indicate a time-dependent increase in
neuronal vulnerability in these brain slice cultures and may be
used to monitor viability of neurons in electrophysiological studies.
Application of a polarity sensitive indicator for viability and
apoptotis (pSIVA) facilitated characterization of neuronal cell
death and survival in 14-day-old PNC. Thus, we developed a
method of long-term whole brain slice cultures (BOSCS) using
brain tissue derived from adult mice – a technique that has rarely
been accomplished [88]. This model seems to be particularly
advantageous in studies of genetically engineered mice.
In summary, the present findings establish a functionally
important role in vivo for caspase 8 in neuronal cell death following
acute brain injury, and encourage the development of therapeutics
that target this protease as potential countermeasures for TBI and
perhaps other causes of acute brain injury. It should be noted
however that humans contain an additional caspase not produced
in mice, namely caspase 10, that may be functionally redundant
with caspase 8. Therefore, therapeutic strategies should also
consider caspase 10, which is structurally and functionally highly
similar to caspase 8 (reviewed in [89]), and thus likely to be
sensitive to the same interventions that neutralize caspase 8.
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